세계의 골밀도계 시장 보고서 : 디바이스 유형, 기술, 용도, 최종 사용자, 지역별(2024-2032년)

The global bone densitometer market size reached US$ 307.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 457.1 Million by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032.

A bone densitometer, also known as a DXA machine, refers to a device that utilizes a minimal dose of ionizing radiation to measure bone loss and the amount of calcium and other minerals in a bone segment. There are two types of DXA equipment, namely central and peripheral devices. The central devices are used to measure the bone density of the hip and spine, and are usually flat and broad, with an arm overhead. On the other hand, peripheral devices are smaller in size and are mainly used to check bone density in wrists, heels, or fingers. It is the standardized method of diagnosing osteoporosis, as it requires no special preparations and a relatively shorter duration than other procedures. It is also used for assessing an individual's risk for developing osteoporotic fractures.

One of the major drivers of the bone densitometer market is the rise in geriatric population who are highly susceptible to bone-related ailments. This, along with the growing incidents of fragility fracture, is significantly contributing to the market growth. Apart from this, these devices are crucial in diagnosing osteoporosis and osteopenia, owing to which they are widely utilized for bone density testing in several hospitals and healthcare clinics. Other factors, such as advancements in DXA scanners, which have enabled quicker and more accurate diagnosis, along with increasing investments to improve the existing healthcare infrastructure, are expected to further create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bone densitometer market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type, technology, application and end-user.

Breakup by Device Type:

Axial Bone Densitometers

Peripheral Bone Densitometers

Breakup by Technology:

Dual-Energy X-Ray Absorptiometry (DXA)

Single X-Ray Absorptiometry (SXA)

Radiographic Absorptiometry (RA)

Quantitative Computed Tomography (QCT)

Others

Breakup by Application:

Osteoporosis and Osteopenia Diagnosis

Cystic Fibrosis Diagnosis

Body Composition Measurement

Rheumatoid Arthritis Diagnosis

Others

Breakup by End-User:

Hospitals & Specialty Clinics

Diagnostics and Imaging Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Ampall Co. Ltd., BeamMed Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, GE Healthcare, Hologic Inc., Medonica Co. Ltd., Scanflex Healthcare AB, Swissray Global Healthcare Holding Ltd., etc.

Key Questions Answered in This Report:

• How has the global bone densitometer market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global bone densitometer market?
• What is the breakup of the market based on the device type?
• What is the breakup of the market based on the technology?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end-user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global bone densitometer market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Bone Densitometer Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Device Type

• 6.1 Axial Bone Densitometers
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Peripheral Bone Densitometers
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Dual-Energy X-Ray Absorptiometry (DXA)
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Single X-Ray Absorptiometry (SXA)
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Radiographic Absorptiometry (RA)
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Quantitative Computed Tomography (QCT)
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Application

• 8.1 Osteoporosis and Osteopenia Diagnosis
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Cystic Fibrosis Diagnosis
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Body Composition Measurement
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Rheumatoid Arthritis Diagnosis
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End-User

• 9.1 Hospitals & Specialty Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Diagnostics and Imaging Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Ampall Co. Ltd.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 BeamMed Ltd.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Diagnostic Medical Systems Group
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
  • 15.3.4 Echolight S.P.A
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 GE Healthcare
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Hologic Inc.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Medonica Co. Ltd.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Scanflex Healthcare AB
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
  • 15.3.9 Swissray Global Healthcare Holding Ltd.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials